Tetraspanin 8 Subfamily Members Regulate Substrate-Specificity of a Disintegrin and Metalloprotease 17

Cells. 2022 Aug 29;11(17):2683. doi: 10.3390/cells11172683.

Abstract

Ectodomain shedding is an irreversible process to regulate inter- and intracellular signaling. Members of the a disintegrin and metalloprotease (ADAM) family are major mediators of ectodomain shedding. ADAM17 is involved in the processing of multiple substrates including tumor necrosis factor (TNF) α and EGF receptor ligands. Substrates of ADAM17 are selectively processed depending on stimulus and cellular context. However, it still remains largely elusive how substrate selectivity of ADAM17 is regulated. Tetraspanins (Tspan) are multi-membrane-passing proteins that are involved in the organization of plasma membrane micro-domains and diverse biological processes. Closely related members of the Tspan8 subfamily, including CD9, CD81 and Tspan8, are associated with cancer and metastasis. Here, we show that Tspan8 subfamily members use different strategies to regulate ADAM17 substrate selectivity. We demonstrate that in particular Tspan8 associates with both ADAM17 and TNF α and promotes ADAM17-mediated TNF α release through recruitment of ADAM17 into Tspan-enriched micro-domains. Yet, processing of other ADAM17 substrates is not altered by Tspan8. We, therefore, propose that Tspan8 contributes to tumorigenesis through enhanced ADAM17-mediated TNF α release and a resulting increase in tissue inflammation.

Keywords: TNF; inflammation; proteases; tetraspanin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins* / genetics
  • ADAM Proteins* / metabolism
  • Disintegrins*
  • Membrane Proteins
  • Substrate Specificity
  • Tetraspanins / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Disintegrins
  • Membrane Proteins
  • Tetraspanins
  • Tumor Necrosis Factor-alpha
  • ADAM Proteins

Grants and funding

This work was supported by the Deutsche Forschungsgemeinschaft (DFG), Bonn [grant number SFB841, project C1 to D.S.-A. and S.R.-J., grant number SFB877, project A1 to S.R.-J., the Australian Technology Network/Deutscher Akademischer Austauschdienst [project-based personnel exchange program to D.S.-A., 57315783], the Medical Faculty of the Christian-Albrechts-University Kiel [to D.S.-A., F358901] and by the Cluster of Excellence ‘Inflammation at Interfaces’ to S.R.-J. The biomaterial bank BMB-CCC is member of the biobanking network P2N at the Kiel University Medical Faculty and was supported by BMBF-grant 01EY1103.